baber/WOPTO huggingface dataset:
Patent NZ-569927-A (NZ)
Title: Calibration of a fiberoptic faraday effect sensor for measuring current in a conductor
Inventor: BJORN LARS NORGAARD
IPC: G01R35/00
Filed: 2004-05-12
Abstract: A method for calibrating a fiber-optic Faraday Effect sensor (10) used to measure the current in a conductor (50) is disclosed. A light source (46), by way of fiber-optic cable (48), is passed though the faraday sensor (10) then via another fiber-optic cable (52) is sent to a detecting system (54). A separate measurement device (58) and current measurement system (58) also measures the current in the conductor (50), the output of which is processed with the output from the detector (54) by a signal processing unit (56) to calculate a calibration constant.
Patent NZ-571689-A (NZ)
Title: A medical treatment material delivery apparatus using containers and a dispensing nozzle all with a uniform cross-sectional area
Inventor: FOSTER DAVID
IPC: A61F2/46
Filed: 2007-04-25
Abstract: Disclosed is a delivery apparatus (10) for delivering material to a medical treatment site. The apparatus comprises: a plurality of containers (4) for containing the material; a dispensing outlet (6); means (2) for bringing each container into communication with the outlet; and means (16) for transferring material from the containers and through the outlet. The containers have a uniform cross-sectional area along their length. The outlet is provided at the end of a dispensing nozzle (8), the nozzle being aligned with the containers. The nozzle has a uniform cross-sectional area along its length the same as that of the containers.
Patent NZ-574702-A (NZ)
Title: A block cutting gangsaw with a vertical frame for cutting blocks of granite or other hard materials having blades movable with reciprocating and oscillating motion
Inventor: GODI ALESSANDRO
IPC: B28D1/06
Filed: 2007-08-06
Abstract: A block-cutting gangsaw with a vertical frame for cutting blocks of granite or other hard materials is disclosed. The block-cutting gangsaw comprises a frame holding blades, which is moveable with reciprocating and oscillating motion, so as to determine a curved cutting trajectory on the block. The blade-holding frame is supported by an oscillating frame which imparts oscillating movement to the blade-holding frame, and the blade-holding frame is moveable with a reciprocating movement relative to the oscillating frame, so that each blade of the blade-holding frame is always in contact with the block. A contact area between each blade and the block moves along a convex, curved trajectory where the oscillating frame is constrained not to traverse vertically by lateral engagement means designed to engage with complementary means fitted to a fixed structure of the gangsaw and further complementary sliding lateral engagement means.
Patent NZ-577402-A (NZ)
Title: Electronic system, methods and apparatus for teaching and examining music theory
Inventor: ADAMS JONATHAN
IPC: G09B15/00
Filed: 2007-12-13
Abstract: Disclosed is a system (100) for teaching and examining in the field of music. Included in the system are a display (110) to present a user with one or more musical tasks and a menu with one or more selectable icons, an input device (120) allowing selection of the one or more icons and a processor (130) in communication with the input device and the display. The processor is arranged to enable the user to form an element of musical notation with the input device upon selection of one of the selectable icons. The processor can then compare one or more characteristics of the element of musical notation with one or more predetermined thresholds and generate a mark based on the result of this comparison.
Patent NZ-582278-A (NZ)
Title: Syringe with disabling lock to prevent reuse and an indicator for showing the position of the lock
Inventor: CAIZZA RICHARD
IPC: A61M5/50
Filed: 2008-06-12
Abstract: Disclosed is a syringe assembly which includes a barrel with a cylindrical sidewall having an interior surface defining a chamber for retaining fluid, an open proximal end and a distal end with a distal wall having an opening therethrough in fluid communication with the chamber. The assembly includes an elongate plunger rod having a proximal end, a distal end, a stopper-engaging portion located at the distal end of the plunger rod, a thumb press at the proximal end of the plunger rod, and a main body portion extending between the distal and proximal ends of the plunger rod. The assembly also includes a stopper having a proximal end and a distal end. The stopper is attached to the stopper-engaging portion of the plunger rod. The stopper is distally and proximally movable relative to the stopper-engaging portion. The assembly includes a lock for locking the plunger rod in the barrel to prevent reuse of the syringe assembly when the distal end of the stopper is in contact with the distal wall of the barrel and distal force is applied to the thumb press. The assembly further includes means for separating plunger rod from the main body upon application of sufficient proximal force to the plunger rod, and an indicator for indicating that the plunger rod is locked in the barrel.
Patent NZ-583041-A (NZ)
Title: Novel antibodies inhibiting c-met dimerization, and uses thereof
Inventor: GOETSCH LILIANE
IPC: A61P35/00
Filed: 2008-07-10
Abstract: Disclosed is an isolated antibody, or one of its functional divalent fragments capable of binding to c-Met, wherein said isolated antibody or said functional divalent fragments comprise a heavy chain comprising CDR- H1, CDR-H2 and CDR-H3 comprising, respectively, the amino acid sequence set forth in SEQ ID Nos. 1, 2 and 3; and a light chain comprising CDR-L1, CDR-L2 and CDR-L3 comprising, respectively, the amino acid sequence set forth in SEQ ID Nos. 10, 11 and 12.
Patent NZ-583647-A (NZ)
Title: Process and intermediates for preparing integrase inhibitors
Inventor: DOWDY ERIC
IPC: C07C43/23
Filed: 2008-09-11
Abstract: Disclosed is a method for preparing a compound of formula 10 or a salt thereof, in which a compound of formula 4 or a salt thereof is prepared and converted into a compound of formula 10, wherein the compound of formula 4 is prepared from a compound of formula 15 or a salt thereof, by metalating the compound of formula 15 or a salt thereof and treating with carbon dioxide to provide the compound of formula 3 or a salt thereof, and converting the compound of formula 3 to provide the compound of formula 4.
Patent NZ-584846-A (NZ)
Title: Use of 3, 11b-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis
Inventor: DUFFIELD ANDREW JOHN
IPC: A61K31/4745
Filed: 2008-10-29
Abstract: Disclosed is the use of a compound for the manufacture of a medicament for treating multiple sclerosis or autoimmune myelitis wherein the compound is a 3, 11b-cisdihydrotetrabenazine of the formula (Ia) or a pharmaceutically acceptable salt thereof.
Patent NZ-594253-A (NZ)
Title: Process for the preparation of 5-/6-nitrofluorescein
Inventor: WHARTON STUART
IPC: C07D493/10
Filed: 2010-02-10
Abstract: Disclosed is a process for the preparation of a mixture of 3',6'-dihydroxy-6-nitrospiro[2-benzofuran-3,9'-xanthene]-1-one and 3',6'-dihydroxy-5-nitrospiro[2-benzofuran-3,9'-xanthene]-1-one comprising the steps of: (a) reacting 4-nitrophthalic acid or 4-nitrophthalic anhydride with benzene-1,3-diol in methanesulphonic acid; (b) quenching the reaction in step (a) with a solvent to precipitate product; (c) isolating the precipitate; (d) heating the precipitate in water in order to hydrolyse any methansulphonic acid ester present.
Patent NZ-594608-A (NZ)
Title: System and method for buffered wireless device enrollment in a security system
Inventor: BELL DWAYNE A
IPC: G08B25/10
Filed: 2010-03-12
Abstract: A system and a method for enrolling wireless devices (4) in a security system are disclosed. The system comprises a controller (6) having a processor and a memory, a plurality of wireless devices, and a machine-readable storage medium encoded with a computer program code such that, when the computer program code is executed by a processor. The processor performs a method comprising receiving a wireless signal from each of the plurality of wireless devices by the controller. The wireless signal from each wireless device contains an enrol command and a unique identifier associated with that wireless device. The method performed by the processor further comprises storing the unique identifiers in the memory; requesting manual confirmation of enrolment of at least one of the plurality of wireless devices and ignoring at least one of the plurality of wireless devices such that the at least one ignored wireless device does not become enrolled in the system. At least one of the ignored wireless devices of the plurality of wireless devices is part of a secondary wireless security system or is in the process of being enrolled in the second wireless security system. Each of the plurality of wireless devices transmit the enrol command and the unique identifier based on a staggered timing pattern.
Patent NZ-596476-A (NZ)
Title: Updating a device in a smart meter system using recognition of unique identifiers over a combination of networks
Inventor: ANSARI ADIL
IPC: H04W4/24
Filed: 2011-11-16
Abstract: Disclosed is a method and system for communication using a meter (106). The method includes receiving via a first network (202), by a meter (106) connected to the first network (202) and connected to a second network (110), information for a device (204) operably connected to said first network (202) such that the information includes a unique identifier for said device (204). The method further includes transmitting via the second network (110), by the meter (106) connected to the first network (202) and the second network (110), at least the unique identifier (304) of the device (204) and a meter identifier (302) that uniquely identifies the meter (106) to a second computing device (108) connected to the second network (110) wherein the second network (110) is a smart-grid network. The unique identifier for the device (204) and the meter identifier are received by said second computing device (108). A third network receives network update information for the device (204) by said second computing device (108) and the second computing device (108) transmits the update information to the meter (106) via the second network (110) using the unique identifier for the device (204) and the meter identifier. The meter (106) then transmits the update information to the device (204) and updates the device (204) with the update information.
Patent NZ-597533-A (NZ)
Title: Apoptosis signal-regulating kinase inhibitors
Inventor: NOTTE GREGORY
IPC: A61K31/4178
Filed: 2010-07-12
Abstract: 597533 Disclosed are N-(6-(4-alkyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-benzamide and N-(3-(4-alkyl-4H-1,2,4-triazol-3-yl)phenyl)-picolinamide derivatives as represented by the general formula (I), wherein: R1 is alkyl, cycloalkyl, alkenyl, alkynyl, aryl, heteroaryl or heterocyclyl, all of which may be optionally substituted, provided that R1 is not methyl when R3 is morpholinyl or furyl; R2 is hydrogen, halo, cyano, alkoxy, or optionally substituted alkyl; R3 is aryl, heteroaryl, or heterocyclyl, all of which are optionally substituted, with the proviso that the heteroaryl or heterocyclyl moiety includes at least one ring nitrogen atom; X1, X2, X3, X4, X5, X6, X7 and X8 are independently C(R4) or N; or X5 and X6 or X6 and X7 are joined to provide fused cycloalkyl, fused aryl, or fused heteroaryl, all of which are optionally substituted; and with the proviso that at least one of X2, X3, and X4 is C(R4); at least two of X5, X6, X7, and X8 are C(R4); and at least one of X2, X3, X4, X5, X6, X7 and X8 is N. Representative compounds include N-(3-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)phenyl)-4-(imidazo[1,2-a]pyridin-3-yl)picolinamide, 6-cyclopropyl-N-(6-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-3,4’-bipyridine-2’-carboxamide, N-(6-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-4-(5-methyl-4-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-1-yl)picolinamide, N-(3-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)phenyl)-4-(6-cyclopropylpyridin-3-yl)-7,8-dimethylquinoline-2-carboxamide, N-(3-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-5-phenylnicotinamide, 5-(2,5-difluorophenyl)-N-(3-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)nicotinamide, N-(6-(1-cyclopropyl-1H-imidazol-5-yl)pyridin-2-yl)-4-(4,5-dimethyl-1H-imidazol-1-yl)picolinamide, N-(6-(1-cyclopropyl-1H-imidazol-5-yl)pyridin-2-yl)-6-(2-hydroxypropan-2-yl)-3,4’-bipyridine-2’-carboxamide or 4-(1H-benzo[d]imidazol-1-yl)-N-(3-(1-cyclopropyl-1H-imidazol-5-yl)phenyl)picolinamide. Further disclosed is a pharmaceutical composition as an ASK1 inhibitor, comprising an effective amount of one or more compounds of Formula (I) as defined above, and a pharmaceutically acceptable carrier, for treating conditions such as autoimmune disorders, inflammatory diseases, cardiovascular diseases and neurodegenerative diseases.
Patent NZ-601169-A (NZ)
Title: Frozen fresh cream to be whipped, method for producing the frozen fresh cream, whipped cream, and method for producing the whipped cream
Inventor: SATORU WAKANA
IPC: A23L3/36
Filed: 2011-09-20
Abstract: A method for cooling fresh cream that will subsequently be thawed and whipped is described. The method seeks to avoid separation and the formation of ice crystals within the fresh cream during the chilling process by freezing it within a designated timeframe. The cream is cooled from 0°C to -5°C within 8 minutes.
Patent NZ-606587-A (NZ)
Title: Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof
Inventor: PIRYATINSKY VICTOR
IPC: C07D215/56
Filed: 2011-07-08
Abstract: The disclosure provides deuterated N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide (deuterated laquinimod), its salts, pharmaceutical compositions comprising them and uses. Disclosed uses include treatment of autoimmune diseases such as Multiple Sclerosis, Systemic Lupus Erythematosus, lupus nephritis, lupus arthritis, Crohn’s Disease or Rheumatoid arthritis.
Patent NZ-609922-A (NZ)
Title: Device to assist in putting on and taking off clothing
Inventor: CARBRAY WILLIAM
IPC: A47G25/90
Filed: 2011-09-21
Abstract: Each unit of a pair of hand-held units for assisting people with diminished flexibility to put on or remove underpants, incontinence pants or elastic waist trousers and slacks, has a handle 1, shaft 2, and head 3. The handle and head are respectively connected to opposite ends of the shaft. Each head 3 has an external convex surface covered with a fabric gripping material 4 and is designed to hold the weight of the garment and to hold the garment in an open position when the fabric gripping material is engaged with the internal surface of the waistband of the garment.
Patent NZ-626973-A (NZ)
Title: Heterocyclic compounds and methods for their use
Inventor: MCCARTHY THOMAS DAVID
IPC: C07D498/10
Filed: 2013-01-04
Abstract: The present invention relates to heterocyclic compounds useful for antagonising angiotensin II Type 2 (AT2) receptor. More particularly the invention relates to pyrrolidine and azetidine compounds, compositions containing them and their use in methods of treating or preventing disorders or diseases associated with AT2 receptor function including neuropathic pain, inflammatory pain, conditions associated with neuronal hypersensitivity, impaired nerve conduction velocity, cell proliferation disorders, disorders associated with an imbalance between bone resorption and bone formation and disorders associated with aberrant nerve regeneration.
Patent NZ-628843-A (NZ)
Title: Methods and compositions for diagnosis and prognosis of renal injury and renal failure
Inventor: ANDERBERG JOSEPH
IPC: G01N33/48
Filed: 2009-10-21
Abstract: Disclosed is an ex vivo method for evaluating renal status in a subject, comprising: -performing one or more ex vivo assays configured to detect Tissue inhibitor of metalloproteinase 1 (TIMP-1) in a body fluid sample obtained previously from the subject; -correlating the assay result(s) to the renal status of the subject by comparing a measured concentration of TIMP-1 from the assay result(s) to a threshold concentration of TIMP-1 and: (i) assigning a likelihood of an event occurring within 72 hours of when the body fluid sample was obtained, when the measured concentration is above the threshold concentration; or (ii) assigning a likelihood of an event not occurring within 72 hours of when the body fluid sample was obtained, when the measured concentration is below the threshold concentration.
Patent NZ-630807-A (NZ)
Title: Kinase inhibitors for the treatment of cancer
Inventor: MORRIS DAVID LAWSON
IPC: C07C317/14
Filed: 2013-03-22
Abstract: Disclosed are aminoacetonitrile derivatives of formula (I) that are useful in the treatment of cancer through kinase inhibition. The types of cancer that can be treated include ovarian cancer, breast cancer, prostate cancer and mesothelioma. One specific compound is: MPL (N-[(1S)-1-cyano-2-(5-cyano-2-trifluoromethyl-phenoxy)-1-methyl-ethyl]-4-trifluoromethylsulfanylbenzamide)
Patent NZ-700640-A (NZ)
Title: Method for preparation of medetomidine
Inventor: ZARAGOZA DOERWALD FLORENCIO
IPC: C07D303/04
Filed: 2012-11-15
Abstract: The technical problem of the invention relates to a method for the preparation of medetomidine starting from 1-bromo-2,3-dimethylbenzene and acetone. Medetomidine is the compound of formula (XX) and is an alpha2 adrenergic agonist, which is currently being used as a veterinary sedative and analgesic and is evaluated as anesthetic. The solution to the problem involves a method which comprises a step (N) and a step (M1); step (M1) comprises a reaction (M1-reac); reaction (M1-reac) is a reaction between a compound selected from the group consisting of a compound of formula (XXI), a hydrate of the compound of formula (XXI) and a hemiacetal of the compound of formula (XXI); said hemiacetal of the compound of formula (XXI) being the product of an addition reaction between the aldehyde as depicted in formula (XXI) and an alcohol selected from the group consisting of tert-butanol and isopropanol, and a reagent (M-reag) and a reagent (M-A) in a solvent (M-solv); reagent (M-reag) is selected from the group consisting of p-toluenesulfonylmethyl isocyanide, trifluoromethanesulfonylmethyl isocyanide, methanesulfonylmethyl isocyanide, benzenesulfonylmethyl isocyanide, 4-acetamidobenzenesulfonylmethyl isocyanide and mixtures thereof; reagent (M-A) is selected from the group consisting of ammonia, sulfamic acid, p-toluenesulfonamide, benzenesulfonamide, 4-acetamidobenzenesulfonamide, tritylamine, formamide, urea, urotropine, ethyl carbamate, acetamide and mixtures thereof; solvent (M-solv) is selected from the group consisting of N,N-dimethylformamide, C1-6 alkanol, formamide, 1,2-dimethoxyethane, NMP, toluene, acetonitrile, propionitrile, ethyl carbamate, N,N-dimethylacetamide, water, acetamide and mixtures thereof; and wherein the compound of formula (XXI) is prepared in the step (N); step (N) comprises a reaction (N-reac); reaction (N-reac) is a reaction of a compound of formula (XXII) with a catalyst (N-cat); catalyst (N-cat) is selected from the group consisting of acetic acid, formic acid, trifluoroacetic acid, methanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid, HCl, HBr, H2SO4, HNO3, H3PO4, HClO4, BCl3, BBr3, BF3OEt2, BF3SMe2, BF3THF, MgCl2, MgBr2, MgI2, AlCl3, Al(O-C1-4 alkyl)3, SnCl4, TiCl4, Ti(O C1-4 alkyl)4, ZrCl4, Bi2O3, BiCl3, ZnCl2, PbCl2, FeCl3, ScCl3, NiCl2, Yb(OTf)3, Yb(Cl)3, GaCl3, AlBr3, Ce(OTf)3, LiCl, Cu(BF4)2, Cu(OTf)2, NiBr2(PPh3)2, NiBr2, NiCl2, Pd(OAc)2, PdCl2, PtCl2, InCl3, acidic inorganic solid substance, acidic ion exchange resin, carbon treated with inorganic acid and mixtures thereof.
Patent NZ-704887-A (NZ)
Title: Resealable beverage containers and methods of making same
Inventor: ZABALETA DANIEL A
IPC: B65D41/28
Filed: 2013-08-08
Abstract: A resealable beverage container includes a cap that moves between storage, opening, removal and resealing positions. Ramps are used to enhance an opening force generally delivered by the engagement between the socket and the cap. An elastomeric sealing element is disposed between the cap and the socket so that when the cap is in the fully seated or sealed position, an airtight or at least substantially airtight seal is created to prevent the contents of the container from leaking out. Further enhancements are disclosed that include a score line structure in the socket bottom wall that facilitates a predictable and repeatable opening of the container along the score line. A grip is provided that includes a gap or space into which a coin or other implement can be inserted to allow the consumer a better grip to provide adequate opening force.
Patent NZ-715331-A (NZ)
Title: Substituted (e)-n’-(1-phenylethylidene) benzohydrazide analogs as histone demethylase inhibitors
Inventor: VANKAYALAPATI HARIPRASAD
IPC: C07D401/12
Filed: 2014-06-19
Abstract: Substituted (E)-N’-(1-phenylethylidene)benzohydrazide analogs or (3-(5-chloro-2-hydroxyphenyl)-4-METHYL-1 H-pyrazol-1-YL)(3- (morpholinosulfonyl)phenyl)methanone, derivatives thereof, and related compounds are useful as inhibitors of lysine-specific histone demethylase, including LSD1. Synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of using the compounds and compositions to treat disorders associated with dysfunction of the LSD1 (lysine-specific demethylase). A pharmaceutically acceptable salt, hydrate, solvate, or polymorph thereof, and one or more of: (a) at least one agent known to increase histone demethylase activity; (b) at least one agent known to decrease histone demethylase activity; (c) at least one agent known to treat a disorder of uncontrolled cellular proliferation; (d) at least one agent known to treat a neurodegenerative disorder; (e) instructions for treating a neurodegenerative disorder; or (f) instructions for treating a disorder associated with uncontrolled cellular proliferation.
Patent NZ-717329-A (NZ)
Title: Nitrogen-containing heterocyclic compound or salt thereof
Inventor: TAKASAKI MASARU
IPC: C07D239/49
Filed: 2013-04-16
Abstract: The object is to provide an Fms-like tyrosine kinase 3 (FLT3) inhibitor useful as a therapeutic agent for acute myeloid leukemia (AML). A novel nitrogen-containing heterocyclic compound represented by the general formula [1] or a salt thereof is provided. The compound or a salt thereof of the present invention can be used as an active ingredient of a pharmaceutical composition for a treatment of a disease or condition relating to FLT3, such as acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL).
Patent NZ-737956-A (NZ)
Title: Immunotherapy against several tumors including gastrointestinal and gastric cancer
Inventor: FRITSCHE JENS
IPC: A61K39/00
Filed: 2011-03-15
Abstract: Disclosed is a peptide consisting the amino acid sequence of SEQ ID No. 86 YLYGQTTTYL. Disclosed is the use of a peptide consisting of the sequence according to SEQ ID No. 86 YLYGQTTTYL which is derived from TOP2A in the manufacture of a medicament for the treatment of cancer, wherein said cancer is gastric, gastrointestinal, colorectal, pancreatic, lung or renal cancer.
Patent NZ-749855-A (NZ)
Title: Cooling acetylated wood elements
Inventor: KAPPEN THEODORUS GERARDUS MARINUS MARIA
IPC: F26B11/04
Filed: 2017-06-23
Abstract: The invention pertains to a process for the production of acetylated wood elements, a cooling system and a wood acetylation plant are described. There is a need for better cooling methods for in particular acetylated wood elements and processes incorporating such methods. The inventive process for the production of acetylated wood elements, comprises acetylating wood elements and cooling the acetylated wood elements by supplying liquid water to the acetylated wood elements to provide wetted wood elements and exposing the wetted wood elements to a gas flow thereby providing for evaporative cooling of hot acetylated wood elements.